Patents by Inventor Qiang PU

Qiang PU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridinyl morpholine compound, preparation method therefor, and application thereof
    Patent number: 12410136
    Abstract: Disclosed in the present invention are a pyridinyl morpholine compound, a preparation method therefor, and an application thereof. The present invention provides a pyridinyl morpholine compound as represented by formula I, a pharmaceutically acceptable salt thereof or a hydrate of the pharmaceutically acceptable salt thereof. The compound can be used as an antagonist for one or more of D2, D3 or 5-HT2A, and is used for preparing a drug for treating schizophrenia.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: September 9, 2025
    Assignees: SHANGHAI ZHONGZE THERAPEUTICS, CO. LTD., SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
    Inventors: Jianqi Li, Yangli Qi, Xiaowen Chen, Junwei Xu, Ruixiang Yuan, Qiang Pu
  • CARRIER PLATFORM, DETECTION DEVICE AND BASE THEREFOR
    Publication number: 20250144817
    Abstract: The present disclosure provides a carrier platform, a detection device and a base thereof. The carrier platform includes a carrier unit configured to carry a display module and a suction nozzle disposed on the carrier unit. The carrier platform further includes a negative pressure assembly, configured to provide a negative pressure to the suction nozzle to enable the suction nozzle to adsorb the display module located on the carrier unit.
    Type: Application
    Filed: January 16, 2023
    Publication date: May 8, 2025
    Inventors: Xue MENG, Qiang PU, Fei ZENG, Guodong ZHOU, Xin MOU, Rongkun FAN, Jialin WANG, Haitao LIANG
  • PYRIDINYL MORPHOLINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
    Publication number: 20230242486
    Abstract: Disclosed in the present invention are a pyridinyl morpholine compound, a preparation method therefor, and an application thereof. The present invention provides a pyridinyl morpholine compound as represented by formula I, a pharmaceutically acceptable salt thereof or a hydrate of the pharmaceutically acceptable salt thereof. The compound can be used as an antagonist for one or more of D2, D3 or 5-HT2A, and is used for preparing a drug for treating schizophrenia.
    Type: Application
    Filed: May 28, 2021
    Publication date: August 3, 2023
    Inventors: Jianqi LI, Yangli QI, Xiaowen CHEN, Junwei XU, Ruixiang YUAN, Qiang PU
  • BENZONITRIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20230159463
    Abstract: Disclosed are a benzonitric heterocyclic compound, a preparation method therefor and the use thereof. Provided in the present invention is a benzonitric heterocyclic compound represented by formula I, or a pharmaceutically acceptable salt thereof, which can be used as a histone deacetylase inhibitor, has a selective inhibitory effect on HDAC6, and has characteristics such as a high efficiency, low toxicity and ideal pharmacokinetic properties.
    Type: Application
    Filed: April 14, 2021
    Publication date: May 25, 2023
    Inventors: Jianqi LI, Zheng GUO, Qingwei ZHANG, Qiang PU, Zixue ZHANG, Minru JIAO
  • AC charging pile
    Patent number: D1099023
    Type: Grant
    Filed: November 7, 2023
    Date of Patent: October 21, 2025
    Inventors: Jie Li, Qiang Pu